Try our Advanced Search for more refined results
June 14, 2016
Janssen Biotech v. Hyclone Laboratories
Case Number:
1:16-cv-00071
Court:
Nature of Suit:
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 15, 2016
Janssen Hits GE Unit With Patent Suit Over Biosimilar
Janssen Biotech Inc. on Tuesday accused a General Electric unit in Utah federal court of infringing its patent for a cell culture media used to grow Inflectra, Celltrion Healthcare Co. and Hospira Inc.'s biosimilar of Janssen's blockbuster immunosuppressant Remicade.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login